Our research showed that the expression levels of TRMT6 correlate with ovarian cancer staging, but the expression levels of TRMT6 demonstrated no significant correlation with other clinicopathological features, such as lymph node metastasis or omental metastasis. This evidence concerns the gene TRMT6 and ovarian carcinoma.